Highlights Semaglutide is a prescription medication
It works by mimicking the effects of the hormone glucagon-like peptide-1 (GLP-1), which is naturally produced in the body
The integration of continuous glucose monitors (CGM) with peptide therapy allows real-time feedback on metabolic responses
doi: 10.3389/fendo.2025.1501984 Received 26 September 2024 Accepted 25 April 2025 Published 26 May 2025 Volume 16 - 2025 Edited by Hwi Seung Kim, Chung-Ang University Gwangmyeong Hospital, Republic of Korea Reviewed by Andrej Belani, Clinical Hospital Centre Rijeka, Croatia ukasz Budak, Medical University of Silesia, Poland Updates Copyright 2025 Oe, Omori, Aimono, Furukawa, Kitakawa, Tateno, Sakai and Cho
The PlexusDx Precision Peptide Genetic Test identifies your genetic variants in key pathwaysincluding GLP1R rs6923761, GIPR rs1800437, and MC4R rs17782313that influence your sensitivity to semaglutide and your energy metabolism